期刊文献+

干扰素调节因子8与肿瘤的关系研究 被引量:4

Recent advances in research of interferon regulatory factor 8 in tumor
下载PDF
导出
摘要 干扰素调节因子8作为干扰素调节因子家族成员,在肿瘤发生以及抗肿瘤免疫中发挥着重要的作用。该文对干扰素调节因子8在肿瘤中的研究进展进行综述。 As a member of IRFs family ,IRF8 plays an important role in the oncogenesis and antitumor immunity .In the present review , we aim at summarizing our current knowledge of the roles of IRF 8 in the regulation of oncogenesis .
出处 《安徽医药》 CAS 2014年第9期1609-1613,共5页 Anhui Medical and Pharmaceutical Journal
基金 国家自然科学基金(No H3105)
关键词 干扰素调节因子8 干扰素同源序列结合蛋白 抗肿瘤免疫 肿瘤发生 interferon regulatory factor 8 interferon consensus sequence binding protein antitumor immunity oncogenesis
  • 相关文献

参考文献41

  • 1Burkholder B, Burgess R, Luo S, et al. Tumor-induced perturbations of cytokines and immune cell networks [J] . Biochimica et Biophysica Acta (BBA) -Reviews on Cancer, 2014 ,1845: 182 - 201.
  • 2Yanai H, Negishi H, Taniguchi T. The IRF family of transcription factors [J] . Oncoimmunology ,2012,1 (8) : 1376 -1386.
  • 3Huang W, Hu L, Bei L, et al. The leukemia-associated fusion protein Tel-platelet-derived growth factor receptor ~ (Tel-PdgfR~) inhibits transcriptional repression of PTPN13 gene by interferon consensus sequence binding protein (Icsbp) [J] . Journal of Biological Chemistry,2012,287(11) :8110 -8125.
  • 4Chang TH, Xu S, Tailor P, et al. The small ubiquitin-like modifierdeconjugating enzyme sentrin-specific peptidase 1 switches IFN regulatory factor 8 from a repressor to an activator during macrophage activation[J] . The Journal of Immunology,2012,189(7): 3548 -3556.
  • 5Laljee RP, Muddaiah S, Salagundi B, et al. Interferon stimulated gene-ISG15 is a potential diagnostic biomarker in oral squamous cell carcinomas [J] . Asian Pac J Cancer Prev, 2013 , 14 : 1147 - 1150.
  • 6Kurotaki D, Osato N, Nishiyama A, et al. Essential role of the IRF8 - KLF4 transcription factor cascade in murine monocyte differentiation[J] . Blood,2013 ,121 (10) : 1839 -1849.
  • 7Barnea- Yizhar 0, Fourier N, Azriel A, et al. An intron of IRF-8 harbors myeloid lineage specific regulatory element that is regulated by dynamic chromatin architecture [J] . Cytokine, 2013 , 63 (3) :246.
  • 8Watanabe T, Hotta C, Koizumi SI, et al. The transcription factor IRF8 counteracts BCR - ABL to rescue dendriticcell development in chronic myelogenous leukemia [J] . Cancer Res, 2013 ,73 ( 22 ) : 6642 -6653.
  • 9Yang J, Hu X, Zimmerman M, et al. Cutting edge: IRF8 regulates Bax transcription in vivo in primary myeloid cells [J] . The Journal of Immunology ,2011,187 (9) :4426 -4430.
  • 10Sung JY, Kim H, Kim YN, et al. Interferon consensus sequence binding protein-induced cell proliferation is mediated by TGF-β signaling and p38 MAPK activation [J] . Laboratory Investigation, 2011 ,91(9) :1304 -1313.

二级参考文献43

  • 1李晓翠,曹丽,傅庆诏.反义基因治疗在卵巢癌中的应用[J].国外医学(肿瘤学分册),2005,32(10):790-793. 被引量:2
  • 2张娇,刘倩,王杰,毛海婷.FasL反义寡核苷酸逆转肝癌细胞免疫逃逸的实验研究[J].中国现代普通外科进展,2006,9(3):147-150. 被引量:6
  • 3陈乔尔,王元银,李倩,周健.口腔黏膜癌前病变和口腔鳞癌组织Fas/FasL的表达及其意义[J].临床口腔医学杂志,2006,22(7):413-416. 被引量:3
  • 4Kalushkova A, Fryknas M, Lemaire M, et al. Polycomb target genes are silenced in multiple myeloma. PLoS ONE ,2010 ;5 (7) : e11483.
  • 5Simon JA, Lange CA. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res,2008 ; 647( 1 -2) :21 -29.
  • 6Huang W, Zhu CL, Wang H, et al. The interferon consensus sequence-binding protein ( ICSBP/IRF8 ) represses PTPN13 gene transcription in differentiating myeloid cells. J Biol Chem, 2008; 283 (12) :7921 - 7935.
  • 7Yang D, Thangaraju M, Greeneltch K, et al. Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic phenotype in metastatic tumor ceils. Cancer Res,2007 ; 67 (7) : 3301 - 3309.
  • 8Tshuikina M, Jernberg-Wiklund H, Nilsson K, et al. Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma. Exp Hematol, 2008 ;36(12) :1673 - 1681.
  • 9Sharma A, Heuck CJ, Fazzari MJ, et al. DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer. Wiley /nterdiscip Rev Syst Bio Med, 2010 ; 2 ( 6 ) : 654 - 669.
  • 10Croonquist PA, Van Ness B. The polycomb group protein enhancer of zeste homolog 2 (EZH2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype. Oncogene, 2005 ; 24(41 ) :6269 -6280.

共引文献16

同被引文献91

  • 1张健,蔡生业.血管平滑肌细胞表型转化及相关信号转导机制探讨[J].心血管病学进展,2005,26(2):185-189. 被引量:17
  • 2曾宪起,申长虹,浦佩玉,杨树源.应用替莫唑胺对照司莫司丁治疗恶性脑胶质瘤的疗效观察[J].中华神经外科杂志,2006,22(4):204-207. 被引量:50
  • 3王文举,李鸿钧,孙茂盛.NF-κB与持久炎症及肿瘤发生关系[J].生命的化学,2007,27(3):197-199. 被引量:16
  • 4余俊,阮秋蓉.心肌素在平滑肌细胞分化及表型调节中的作用[J].中国动脉硬化杂志,2007,15(4):315-317. 被引量:2
  • 5Groves MD, Puduvalli VK, Gilbert MR, et al. Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme. Br J Cancer. 2009; 101 (4):615-620.
  • 6Wang JD, He B, Dai WB, et al. Targeting glioblastoma cancer stem cell marker CD133 by heptapeptide-modified DSPE-PEG micelles. Journal of Chinese Pharmaceutical Sciences. 2015;24(1 ):34-39.
  • 7Colman H, Berkey BA, Maor MH, et al. Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710. Int J Radiat Oncol Biol Phys. 2006;66(3): 818-824.
  • 8Wang D, Chang PS, Wang Z, et al. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell, 2001, 105:851-62.
  • 9Wang J, Li A, Wang Z, et al. Myocardin sumoylation transactivates cardiogenic genes in pluripotent 10T1/2 fibroblasts. Mol Cell Biol, 2007, 27:622-32.
  • 10Stegemann JP, Hong H, Nerem RM. Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype. J Appl Physiol, 2005, 98:2321-7.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部